Company: IMCR
Filing Date: 2025-03-24
Form Type: PRE 14A
Source: 0001140361-25-010035
Chunk: 20

Company: Immunocore Holdings plc
Filing Date: 2025-03-24
Form: PRE 14A
Chunk 20
---
toll free within the United States) or +1-781-575-4555 (for international callers) or by email at citibank@shareholders-online.comor at Citibank Shareholder Services, P.O. Box 43077, Providence, RI 02940-3077. If you hold your ADSs through a custodian, broker or other agent, you should refer to the contact information provided by your agent. What do I do if I have additional questions? If you have any further questions about voting or attending the AGM, please contact our registrar, Computershare, at +44 (0) 370 703 0387 or corporate-representatives@computershare.co.uk. 10

TABLE OF CONTENTS

BACKGROUND TO RESOLUTIONS 1 TO 3—RE-APPOINTMENT OF DIRECTORS Our board of directors currently consists of nine directors, and is divided into three classes as follows:

| • | Class I directors: Roy S. Herbst, M.D., Ph.D., Ranjeev Krishana and Professor Sir Peter Ratcliffe, whose current terms will expire at the upcoming AGM; |

| • | Class II directors: Siddharth Kaul, William Pao, M.D., Ph.D., Robert Perez and Kristine Peterson, whose current terms will expire at the 2026 annual general meeting of shareholders; and |

| • | Class III directors: Bahija Jallal, Ph.D. and Professor Sir John Bell, whose current terms will expire at the 2027 annual general meeting of shareholders. |

Under our articles of association, each director in Class I (whose terms expire at the AGM) will retire from office at the AGM but will be eligible for re-appointment by ordinary resolution at the AGM and, in each case, where such director is so re-appointed, they will be entitled to serve for a term of three years from the AGM. In accordance with this requirement, each of Roy S. Herbst, M.D., Ph.D., Ranjeev Krishana and Professor Sir Peter Ratcliffe will retire and offer themselves for re-appointment as Class I directors at the upcoming AGM. Our board of directors has nominated Roy S. Herbst, M.D., Ph.D. Ranjeev Krishana and Professor Sir Peter Ratcliffe for re-appointment as Class I directors and no other nominees for directors have been presented. If elected, each of the nominees will hold office from the date of re- appointment